The long-term observation of the beneficial effects of treatment: 0.12 mg Anti-VEGF monotherapy or anti-VEGF combined therapy and diode-laser in various stages of retinopathy of prematurity-series of cases. „J. Clin. Med.” 2023, 12, s.5644 (dostęp 15.12.2025) Most up-to-date analysis of epidemiological data on the screening guidelines and incidence of retinopathy of prematurity in Europe - a literature review. „J. Clin. Med.” 2023, 12, 11, s. (wsp. Wiktoria Bosy-Gąsior)Monika Modrzejewska, Wiktoria Bosy-Gąsior. Most up-to-date analysis of epidemiological data on the screening guidelines and incidence of retinopathy of prematurity in Europe - a literature review. „J. Clin. Med.” 2023, 12, 11, s.3650 (dostęp 15.12.2025) Usefulness assessment of automated strabismus angle measurements using innovative strabiscan device. „J. Clin. Med.” 2024, 13, 1367 (wsp. Ewa Grudzińska, Magdalena Durajczyk, Marek Grudziński, Łukasz Marchewka)Ewa Grudzińska, Magdalena Durajczyk, Marek Grudziński, Łukasz Marchewka, Monika Modrzejewska. Usefulness assessment of automated strabismus angle measurements using innovative strabiscan device. „J. Clin.